Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Incyte Corporation (INCY)

Healthcare Biotechnology
119.50 $
-2.8% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Incyte Corporation (INCY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.1% of the shares are freely tradable; institutional investors hold 106.6%.

Ownership Structure

Institutional ownership
106.6%
Insiders
1.9%
Float
84.1%
Short % of float
9.1%
Shares Outstanding
203Mio.

Largest Shareholders

Institutions

Institutions INCY
Name Stake (%) Shares Change (%) Date
Baker Bros Advisors LP 15.17 30,744,412 +0.0 03/31/2026
BlackRock Inc 9.36 18,978,198 +3.5 03/31/2026
Dodge & Cox 6.04 12,252,356 -7.6 03/31/2026
Vanguard Capital Management, LLC 5.39 10,930,066 +0.0 03/31/2026
State Street Corp 4.76 9,641,384 -0.2 03/31/2026
Vanguard Portfolio Management, LLC 3.83 7,759,183 +0.0 03/31/2026
AQR Capital Management LLC 2.87 5,807,930 -13.6 03/31/2026
Geode Capital Management, LLC 2.32 4,703,184 -5.8 03/31/2026

Funds

Funds INCY
Name Stake (%) Shares Change (%) Date
Dodge & Cox Stock I 3.92 7,953,128 -4.0 06/30/2026
Vanguard Morn Total Stk Mkt Idx Investor 2.66 5,391,866 +0.1 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
16. Jul 2026 Hoffman Richard A. EVP & General Counsel Other 7,395 0.00
16. Jul 2026 Gardner David H EVP, Chief Strategy Officer Other 7,395 0.00
16. Jul 2026 Basi Ramitpal K EVP, Human Resources Other 4,991 0.00
16. Jul 2026 Mayes Patrick A EVP & Chief Scientific Officer Other 5,916 0.00
16. Jul 2026 Issa Mohamed Khairie EVP, Head of U.S. Commercial Other 7,857 0.00
16. Jul 2026 Issa Mohamed Khairie EVP, Head of U.S. Commercial Sell 1,093 115.01 125,706
16. Jul 2026 Tray Thomas Principal Accounting Officer Other 2,834 0.00
16. Jul 2026 Stein Steven H CMO & Head of Late-Stage Dev. Other 9,798 0.00
16. Jul 2026 Stein Steven H CMO & Head of Late-Stage Dev. Sell 1,877 114.73 215,348
16. Jul 2026 Meury William Chief Executive Officer Other 26,807 0.00
16. Jul 2026 Cagnoni Pablo J President, Global Head of R&D Other 13,403 0.00
15. Jul 2026 Mayes Patrick A EVP & Chief Scientific Officer Other 1,512 115.09 174,016
15. Jul 2026 Issa Mohamed Khairie EVP, Head of U.S. Commercial Other 1,099 115.09 126,484
15. Jul 2026 Tray Thomas Principal Accounting Officer Other 1,098 115.09 126,369
15. Jul 2026 Stein Steven H CMO & Head of Late-Stage Dev. Other 3,088 115.09 355,398
15. Jul 2026 Stein Steven H CMO & Head of Late-Stage Dev. Sell 28,237 113.05 3,192,193
15. Jul 2026 Cagnoni Pablo J President, Global Head of R&D Other 4,950 115.09 569,696
14. Jul 2026 Mayes Patrick A EVP & Chief Scientific Officer Other 437 114.88 50,203
14. Jul 2026 Tray Thomas Principal Accounting Officer Other 692 114.88 79,497
14. Jul 2026 Stein Steven H CMO & Head of Late-Stage Dev. Other 21,830 114.88 2,507,830
14. Jul 2026 Cagnoni Pablo J President, Global Head of R&D Other 17,969 114.88 2,064,279

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?